Antigen processing and presentation of a naturally glycosylated protein elicits major histocompatibility complex class II-restricted, carbohydrate-specific T cells

被引:66
作者
Michaelsson, E
Broddefalk, J
Engstrom, A
Kihlberg, J
Holmdahl, R
机构
[1] LUND UNIV,SECT MED INFLAMMAT RES,DEPT CELL & MOL BIOL,S-22100 LUND,SWEDEN
[2] LUND UNIV,DEPT ORGAN CHEM 2,LUND,SWEDEN
[3] UPPSALA UNIV,DEPT MED & PHYSIOL CHEM,UPPSALA,SWEDEN
关键词
post-translational modification; collagen-induced arthritis; glycopeptide; antigen presentation; autoimmunity;
D O I
10.1002/eji.1830260835
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
It is well known that T cells recognize antigen as processed peptides bound to major histocompatibility complex molecules on the surface of antigen-presenting cells. Recently, it has been shown that T cells can specifically recognize synthetic glycopeptides. However, whether glycopeptides are selected for presentation during antigen processing of glycoproteins and eventually elicit carbohydrate-specific T cells is still an open question. In this study, we utilized synthetic glycopeptides to analyze T cell recognition of the naturally glycosylated immunodominant peptide representing type II collagen (CII) residues 256-270. In this peptide, lysines at positions 264 and 270 may be posttranslationally modified by hydroxylation and subsequent O-linked glycosylation with beta-galactosyl or alpha-glucosyl-(1 --> 2)-beta-galactosyl residues. T cell hybridomas established from type II collagen-immunized mice specifically recognized CII 256-270 with either galactose or glucosyl-galactose at position 264. The T cell hybridoma recognizing glucosyl-galactose displayed no cross-reactivity either to galactose cr to the structurally different alpha-galactosyl-(1 --> 4)-beta-galactose. Furthermore, the T cell hybridoma recognizing-galactose did not cross-react to glucosyl-galactose or galactosyl-galactose, indicating that the antigen-presenting cells (bulk spleen cells, lipopolysaccharide-stimulated spleen cells, anti-CD40-stimulated spleen cells, peritoneal exudate cells or CFA-primed lymph node cells) inefficiently processed carbohydrates when the antigen was given as a glycopeptide.
引用
收藏
页码:1906 / 1910
页数:5
相关论文
共 23 条
[1]   ANALYSIS OF TYPE-II COLLAGEN-REACTIVE T-CELLS IN THE MOUSE .1. DIFFERENT REGULATION OF AUTOREACTIVE VS NONAUTOREACTIVE ANTI-TYPE-II COLLAGEN T-CELLS IN THE DBA/1 MOUSE [J].
ANDERSSON, M ;
HOLMDAHL, R .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1990, 20 (05) :1061-1066
[2]  
BRODDEFALK J, 1996, IN PRESS TETRAHEDRON
[3]   SPECIFICITY AND PROMISCUITY AMONG NATURALLY PROCESSED PEPTIDES BOUND TO HLA-DR ALLELES [J].
CHICZ, RM ;
URBAN, RG ;
GORGA, JC ;
VIGNALI, DAA ;
LANE, WS ;
STROMINGER, JL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (01) :27-47
[4]   T-CELL REGULATION OF COLLAGEN-INDUCED ARTHRITIS IN MICE .3. IS T-CELL VACCINATION A VALUABLE THERAPY [J].
CHIOCCHIA, G ;
MANOURYSCHWARTZ, B ;
BOISSIER, MC ;
GAHERY, H ;
MARCHE, PN ;
FOURNIER, C .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (11) :2775-2783
[5]  
DECK B, 1995, J IMMUNOL, V155, P1074
[6]   Specificity of an HLA-DRB1*0401-restricted T cell response to type II collagen [J].
Fugger, L ;
Rothbard, JB ;
SonderstrupMcDevitt, G .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (04) :928-933
[7]   DIFFERENT LEVELS OF GLYCOSYLATION CONTRIBUTE TO THE HETEROGENEITY OF ALPHA-1(II) COLLAGEN CHAINS DERIVED FROM A TRANSPLANTABLE RAT CHONDROSARCOMA [J].
FURUTO, DK ;
MILLER, EJ .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1983, 226 (02) :604-611
[8]  
HARDING CV, 1993, J IMMUNOL, V151, P2419
[9]   EFFECTS OF PH AND POLYSACCHARIDES ON PEPTIDE BINDING TO CLASS-II MAJOR HISTOCOMPATIBILITY COMPLEX-MOLECULES [J].
HARDING, CV ;
ROOF, RW ;
ALLEN, PM ;
UNANUE, ER .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (07) :2740-2744
[10]   RECOGNITION OF CARBOHYDRATE BY MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I-RESTRICTED, GLYCOPEPTIDE-SPECIFIC CYTOTOXIC T-LYMPHOCYTES [J].
HAURUM, JS ;
ARSEQUELL, G ;
LELLOUCH, AC ;
WONG, SYC ;
DWEK, RA ;
MCMICHAEL, AJ ;
ELLIOTT, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (02) :739-744